UNSPSC 85681531: Supplement right orbit with nonautologous tissue substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement right orbit with nonautologous tissue substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0NUP3KZ

UNSPSC 85681531 Supplement right orbit with nonautologous tissue substitute, percutaneous approach is a Commodity code with minimal relevant recent state and local procurement activity. The recent opportunities associated with this code do not align with its clinical surgical scope — they involve inmate medical services contracting, pharmacy benefit management administration, virtual primary care platform services, peer support worker training, and fire department medical direction, none of which constitute ophthalmic surgical procedures or tissue-substitute implantation. State and local health systems and correctional agencies do not typically procure specific surgical interventions through open competitive solicitation; instead, they contract for comprehensive healthcare delivery, insurance administration, or professional medical direction services that may incidentally include such procedures as part of broader clinical service portfolios.

The mismatch between the code's nominal scope and the work actually being solicited suggests this code sees little direct purchasing activity at the state and local level for the specific procedure named. Agencies that require ophthalmic surgical services — whether county health systems, correctional facilities, or municipal clinics — procure them through medical staff credentialing, managed care network agreements, or specialty care referral arrangements rather than discrete procedure-level RFPs. Business development professionals tracking this code should expect sporadic and indirect visibility into relevant procurement rather than direct solicitation for orbital-tissue-substitute procedures.